Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.7400
-0.0300 (-3.90%)
Mar 12, 2026, 3:59 PM EST

Vaxart Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-56.64-66.95-82.47-107.76-70.47-32.22
Depreciation & Amortization
8.98.858.625.814.212.71
Stock-Based Compensation
9.4111.514.1313.598.874.36
Other Adjustments
-2.12-1.430.11-1.72-0.32-1.4
Change in Receivables
-36.29-8.96-2.990.050.263.29
Changes in Accounts Payable
6.845.27-2.440.361.631.21
Changes in Accrued Expenses
26.43.33-6.98-3.32-2.21-0.58
Changes in Unearned Revenue
65.3865.4-22--
Changes in Other Operating Activities
1.14-61.783.56-3.78-1.8-1.11
Operating Cash Flow
-37.09-44.76-70.45-94.78-59.83-23.75
Capital Expenditures
-0.08-0.55-1.87-9.6-5.16-1.22
Sale of Property, Plant & Equipment
--0.12--0
Purchases of Investments
-44.89-64.27-27.5-55.01-44.81-
Proceeds from Sale of Investments
58.843.573.244.25.7-
Payments for Business Acquisitions
-----4.83-
Investing Cash Flow
13.83-21.3243.95-20.42-49.1-1.22
Issuance of Common Stock
0.0256.7815.6117.46125.8137.66
Repurchase of Common Stock
-0.19-0.21-0.37---
Net Common Stock Issued (Repurchased)
-0.1756.5615.2417.46125.8137.66
Other Financing Activities
-----0.65
Financing Cash Flow
0.0956.5615.2417.46125.8138.31
Net Cash Flow
-23.17-9.53-11.26-97.7316.88113.34
Beginning Cash & Cash Equivalents
43.2934.7646.01143.75126.8713.53
Ending Cash & Cash Equivalents
20.1125.2334.7646.01143.75126.87
Free Cash Flow
-37.17-45.32-72.32-104.38-64.99-24.97
FCF Margin
-46.05%-157.90%-980.13%-97551.40%-7285.76%-617.23%
Free Cash Flow Per Share
-0.16-0.22-0.50-0.82-0.54-0.28
Levered Free Cash Flow
51.94-46.43-83.57-116.3-73.8-31.21
Unlevered Free Cash Flow
52.73-46.06-84.73-123.21-76.2-29.42
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.